Viewing Study NCT00741234


Ignite Creation Date: 2025-12-25 @ 2:24 AM
Ignite Modification Date: 2025-12-27 @ 10:58 PM
Study NCT ID: NCT00741234
Status: COMPLETED
Last Update Posted: 2012-04-23
First Post: 2008-08-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I Dose Escalation Study of Oral SB939 Administered Alone or With Azacitidine
Sponsor: S*BIO
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module